SpeakEasy Cannabis Club Ltd. announced the repositioning and new appointments of its Board of Directors in anticipation of receiving its license from Health Canada. Marc Geen will resign as the Company's CEO and the position will be filled by Dr. Bin Huang. Bin, former President and CEO of Emerald Health Therapeutics Inc., comes with a wealth of knowledge and experience in this industry.

Further, the Company announces the following additional changes to its management, Board of Directors and its Advisory Board: Dave Cross will resign as the Company's current Chief Financial Officer however, the day to day financial operations will remain with his firm, Cross Davis and Co. The acting Chief Financial Officer position will be filled by Patrick Geen, who has been involved with the Company since its inception. Along with being appointed to the Board of Directors, Pat is also the Company's Head Grower.

Zena Prokosh has been involved in the project since 2016, in the capacity of Quality Assurance/Quality Control. Along with operational industry experience since 2013, Zena will fulfill her position on the Board by delivering a wealth of knowledge in taking Companies through the Health Canada licensing process. Along with Marc Geens resignation as CEO and board member, Brian Peery, President and board member, Alexander Kaulins, CTO and board member, and Jeremy Ross, board member, will resign from their directors' and officers' positions and join Marc Geen on the Company's Advisory Board.

Mervyn Geen resigns as board of director and Chairman of the Board.